Influence of lipophilicity on the interactions of hydroxy stilbenes with cytochrome P450 3A4

被引:36
|
作者
Regev-Shoshani, G
Shoseyov, O
Kerem, Z
机构
[1] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel
[2] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel
关键词
resveratrol; CYP3A4; piceid; kinetics; cyclosporine; polyphenols;
D O I
10.1016/j.bbrc.2004.08.141
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resveratrol, a polyphenol found in red wine, was recently suggested to act as an irreversible, mechanism-based inactivator of cytochrome P450 3A4 (CYP3A4). We found a significant inhibition of human CYP3A4-dependent transformation of cyclosporine by resveratrol, with IC50 = 4.5 muM. We studied the kinetics parameters of CYP3A4 transformation of resveratrol and structurally related, naturally occurring stilbenes. Resveratrol, piceid, resveratroloside, 5,4'-dihydroxy-3-O-methoxystilbene, and 5,3-dihydroxy-4'-O-methoxystilbene were all shown to inhibit hydroxylation of testosterone by CYP3A4. Both methoxy-stilbenes had lower IC50 values, ranging from 0.43 to 0.47 muM, suggesting that lipophilicity rather than number or positions of free hydroxyls (3,5 or 5,4') determines the CYP3A4 inhibition capacity of polyphenols. In line with these findings, both glucosyl-stilbenes were found to be weak inhibitors of CYP3A4. The affinity of the enzyme towards methoxy-stilbenes, expressed as apparent K-m, was indeed higher than those for the parent resveratrol and its glucosides, in CYP3A4 reaction mixtures. V-max values were similar, except for piceid. These results support the role of lipophilicity in the interaction of polyphenols with CYP3A4. It is suggested that selective structural modifications of substrates add significantly to knowledge acquired through molecular modifications of the enzyme. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:668 / 673
页数:6
相关论文
共 50 条
  • [41] Involvement of human cytochrome P450 3A4 in the metabolism of vamidothion
    Mehmood, Z
    Kelly, DE
    Kelly, SL
    PESTICIDE SCIENCE, 1996, 46 (03): : 287 - 290
  • [42] Fluorescent photoaffinity labeling of cytochrome P450 3A4 by lapachenole
    Wen, B
    Gartner, CA
    Cameron, MD
    Nelson, SD
    DRUG METABOLISM REVIEWS, 2003, 35 : 101 - 101
  • [43] Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
    Gruer, PJK
    Vega, JM
    Mercuri, MF
    Dobrinska, MR
    Tobert, JA
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (07): : 811 - 815
  • [44] Structural basis for ligand promiscuity in cytochrome P450 3A4
    Ekroos, Marika
    Sjogren, Tove
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (37) : 13682 - 13687
  • [45] The effect of antioxidants on electrocatalytic activity of cytochrome P450 3A4
    Shumyantseva V.V.
    Makhova A.A.
    Bulko T.V.
    Shich E.V.
    Kukes V.G.
    Usanov S.A.
    Archakov A.I.
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2013, 7 (2) : 160 - 164
  • [46] Testosterone 1β-hydroxylation by human cytochrome P450 3A4
    Krauser, JA
    Voehler, M
    Tseng, LH
    Schefer, AB
    Godejohann, M
    Guengerich, FP
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (19): : 3962 - 3969
  • [47] Testosterone 1β-hydroxylation by human cytochrome P450 3A4
    Krauser, JA
    Voehler, M
    Tseng, LH
    Schefer, AB
    Godejohann, M
    Guengerich, FP
    DRUG METABOLISM REVIEWS, 2004, 36 : 254 - 254
  • [48] Design and synthesis of a new fluorescent probe for cytochrome P450 3A4 (CYP 3A4)
    Chougnet, A
    Stoessel, C
    Woggon, WD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (21) : 3643 - 3645
  • [49] Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells
    Bertilsson, PM
    Olsson, P
    Magnusson, KE
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (05) : 638 - 646
  • [50] Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes
    Roymans, D
    Van Looveren, C
    Leone, A
    Parker, JB
    McMillian, M
    Johnson, MD
    Koganti, A
    Gilissen, R
    Silber, P
    Mannens, G
    Meuldermans, W
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (03) : 427 - 437